NASDAQ:PRTC
PureTech Health plc
- Stock
Last Close
1.65
01/05 20:00
Market Cap
555.22M
Beta: 0.82
Volume Today
1K
Avg: 765
PE Ratio
−18.26
PFCF: −3.55
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 9.79M - | ||||||||||
average payables | 2.82M - | 3.56M 26.40% | 6.76M 89.70% | 13.74M 103.34% | 10.50M 23.57% | 7.87M 25.05% | 9.98M 26.85% | 10.11M 1.24% | 18.93M 87.22% | 20.57M 8.69% | |
average receivables | 18.29M - | ||||||||||
book value per share | 0.79 - | 1.22 54.94% | 0.77 36.57% | 0.91 17.54% | 1.01 10.57% | 2.36 134.28% | 2.35 0.51% | 2.07 11.69% | 1.68 - | ||
capex per share | -0.00 - | -0.02 1,246.23% | -0.02 35.63% | -0.01 42.45% | -0.02 77.88% | -0.04 169.81% | -0.02 57.07% | -0.02 4.01% | -0.00 - | ||
capex to depreciation | -0.92 - | -6.23 574.89% | -2.34 62.42% | -1.03 55.83% | -1.62 56.27% | -1.88 16.39% | -0.82 56.61% | -0.78 4.83% | -0.24 68.50% | -0.05 79.70% | |
capex to operating cash flow | 0.04 - | 0.16 304.47% | 0.06 60.69% | 0.02 61.35% | 0.06 151.97% | 0.13 107.10% | 0.04 67.79% | 0.04 13.07% | 0.01 65.97% | 0.00 80.99% | |
capex to revenue | -0.21 - | -0.39 88.11% | -0.83 111.27% | -3.34 302.60% | -0.27 91.79% | -1.44 426.18% | -0.65 54.94% | -0.57 12.76% | -1.04 83.53% | -0.33 68.62% | |
cash per share | 0.97 - | 1.70 75.25% | 1.23 27.53% | 0.81 34.54% | 0.92 13.76% | 0.57 37.44% | 1.41 146.73% | 1.62 14.91% | 1.18 - | ||
days of inventory on hand | 430.39 - | ||||||||||
days payables outstanding | -9.93K - | 1.06K - | |||||||||
days sales outstanding | 6.86K - | ||||||||||
debt to assets | 0.03 - | 0.02 50.23% | 0.02 53.48% | 0.02 5.75% | 0.03 27.62% | 0.04 49.15% | 0.08 85.36% | 0.05 28.95% | 0.07 21.30% | 0.04 45.26% | |
debt to equity | 0.04 - | 0.02 43.55% | 0.04 78.59% | 0.03 11.11% | 0.04 29.04% | 0.06 31.05% | 0.11 94.48% | 0.09 23.38% | 0.09 1.38% | 0.05 36.83% | |
dividend yield | 0.00 - | 0.00 - | 0.00 744.22% | 0.00 94.46% | |||||||
earnings yield | -0.08 - | -0.09 16.51% | -0.13 45.11% | 0.07 152.66% | -0.07 201.53% | 0.35 610.45% | 0.00 98.92% | -0.05 1,491.87% | -0.10 - | ||
enterprise value | 331.11M - | 311.17M 6.02% | 320.39M 2.96% | 387.03M 20.80% | 525.17M 35.69% | 1.10B 108.95% | 1.24B 12.81% | 724.08M 41.50% | -102.99M 114.22% | 491.86M 577.56% | |
enterprise value over ebitda | -19.54 - | -6.86 64.91% | -4.14 39.62% | -2.79 32.59% | -4.24 51.84% | -11.57 173.01% | -8.55 26.09% | -3.37 60.60% | 0.51 115.08% | -3.72 831.69% | |
ev to operating cash flow | -31.41 - | -10.88 65.37% | -5.52 49.24% | -4.36 20.96% | -7.21 65.31% | -11.18 54.96% | -9.39 16.01% | -4.57 51.28% | 0.58 112.59% | -4.64 906.15% | |
ev to sales | 164.57 - | 26.51 83.89% | 72.31 172.80% | 595.43 723.47% | 32.08 94.61% | 126.30 293.73% | 148.41 17.50% | 72.56 51.11% | -49.28 167.91% | 655.82 1,430.81% | |
free cash flow per share | -0.05 - | -0.18 271.67% | -0.27 49.96% | -0.39 43.47% | -0.28 26.84% | -0.39 38.39% | -0.48 23.05% | -0.57 19.03% | -0.38 - | ||
free cash flow yield | -0.02 - | -0.08 273.23% | -0.16 117.62% | -0.20 22.55% | -0.12 38.93% | -0.09 24.22% | -0.09 5.69% | -0.14 64.30% | -0.16 - | ||
graham net net | 0.55 - | 0.82 48.04% | 0.33 59.58% | -0.37 210.45% | -0.09 76.13% | -0.45 418.55% | 0.24 152.14% | 0.36 53.49% | 0.38 - | ||
graham number | 1.80 - | 2.42 34.08% | 1.92 20.36% | 1.64 14.88% | 1.90 15.97% | 8.88 367.31% | 1.05 88.15% | 3.14 198.41% | 3.00 - | ||
income quality | 0.14 - | 0.49 253.84% | 0.71 44.76% | 1.25 76.41% | 1.03 17.87% | -0.27 126.03% | -28.86 10,662.66% | 2.52 108.75% | 4.82 91.12% | 1.59 67.04% | |
intangibles to total assets | 0.01 - | 0.01 9.92% | 0.01 0.43% | 0.01 17.46% | 0.01 28.39% | 0.00 90.48% | 0.00 36.75% | 0.00 14.89% | 0.00 13.35% | 0.00 10.39% | |
interest coverage | -6.73 - | -52.27 677.17% | -92.30 76.59% | -208.72 126.14% | -265.35 27.14% | -51.21 80.70% | -40.57 20.77% | -31.88 21.43% | -50.04 56.96% | -10.84 78.34% | |
interest debt per share | 0.04 - | 0.03 25.58% | 0.03 8.11% | 0.03 0.64% | 0.05 37.04% | 0.15 217.62% | 0.28 88.26% | 0.20 28.94% | 0.14 - | ||
inventory turnover | 0.85 - | ||||||||||
invested capital | 0.04 - | 0.02 43.55% | 0.04 78.59% | 0.03 11.11% | 0.04 29.04% | 0.06 31.05% | 0.11 94.48% | 0.09 23.38% | 0.09 1.38% | 0.05 36.83% | |
market cap | 543.12M - | 440.97M 18.81% | 376.40M 14.64% | 452.22M 20.14% | 629.85M 39.28% | 1.19B 89.00% | 1.57B 31.48% | 1.14B 27.30% | 657.60M - | ||
net current asset value | 129.38M - | 155.50M 20.19% | 81.81M 47.39% | -77.74M 195.02% | -15.01M 80.70% | -121.94M 712.63% | 77.89M 163.88% | 139.95M 79.67% | 231.13M 65.15% | 111.46M 51.78% | |
net debt to ebitda | 12.51 - | 2.86 77.14% | 0.72 74.70% | 0.47 35.04% | 0.84 79.68% | 0.98 16.15% | 2.26 130.42% | 1.93 14.85% | 0.51 73.61% | 1.25 146.55% | |
net income per share | -0.18 - | -0.21 16.02% | -0.21 0.01% | 0.13 161.65% | -0.16 221.63% | 1.49 1,032.13% | 0.02 98.59% | -0.21 1,108.34% | -0.24 - | ||
operating cash flow per share | -0.05 - | -0.15 232.84% | -0.25 63.75% | -0.38 48.92% | -0.27 29.40% | -0.35 30.28% | -0.46 33.28% | -0.55 19.65% | -0.38 - | ||
payables turnover | -0.04 - | 0.35 - | |||||||||
receivables turnover | 0.05 - | ||||||||||
research and ddevelopement to revenue | 1.41 - | 1.14 18.98% | 9.30 714.24% | 110.26 1,085.74% | 3.50 96.83% | 7.50 114.33% | 7.34 2.20% | 8.17 11.36% | 55.56 580.07% | 98.31 76.95% | |
return on tangible assets | -0.19 - | -0.12 34.07% | -0.17 35.46% | 0.09 155.50% | -0.10 208.49% | 0.45 549.96% | 0.01 98.65% | -0.06 1,159.02% | -0.07 11.96% | -0.09 32.12% | |
revenue per share | 0.01 - | 0.06 615.66% | 0.02 69.53% | 0.00 85.71% | 0.06 2,066.22% | 0.03 48.72% | 0.03 4.73% | 0.03 19.23% | 0.00 - | ||
roe | -0.23 - | -0.17 25.11% | -0.27 57.64% | 0.14 152.45% | -0.16 210.00% | 0.63 497.87% | 0.01 98.58% | -0.10 1,241.79% | -0.09 8.98% | -0.14 52.44% | |
roic | -0.09 - | -0.20 108.95% | -0.39 101.14% | -0.52 32.46% | -0.37 28.40% | -0.14 62.69% | -0.04 73.51% | -0.24 539.81% | -0.13 45.75% | -0.55 331.32% | |
sales general and administrative to revenue | 3.56 - | 1.57 56.05% | 8.39 435.66% | 71.20 749.17% | 1.49 97.90% | 4.02 169.16% | 3.18 20.90% | 3.08 2.96% | 17.07 453.64% | 33.57 96.72% | |
shareholders equity per share | 0.79 - | 1.22 54.94% | 0.77 36.57% | 0.91 17.54% | 1.01 10.57% | 2.36 134.28% | 2.35 0.51% | 2.07 11.69% | 1.68 - | ||
stock based compensation to revenue | 1.40 - | 0.95 32.36% | 2.29 142.46% | 18.23 695.57% | 0.77 95.77% | 1.67 115.73% | 1.28 22.84% | 1.40 8.79% | 7.03 403.07% | 5.89 16.29% | |
tangible asset value | 130.69M - | 160.18M 22.57% | 88.89M 44.51% | 60.69M 31.72% | 163.89M 170.06% | 649.77M 296.46% | 652.64M 0.44% | 583.16M 10.65% | 546.76M 6.24% | 457.32M 16.36% | |
tangible book value per share | 0.58 - | 0.86 50.33% | 0.39 55.20% | 0.26 33.47% | 0.60 132.27% | 2.29 283.07% | 2.29 0.32% | 2.03 10.95% | 1.66 - | ||
working capital | 130.05M - | 157.68M 21.25% | 84.07M 46.68% | -75.75M 190.10% | -5.98M 92.11% | 29.64M 595.88% | 233.42M 687.42% | 275.67M 18.10% | 289.31M 4.95% | 295.83M 2.26% |
All numbers in USD (except ratios and percentages)